- Home
- CGC vs KRRO Comparison
CGC vs KRRO Comparison
Compare CGC & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGC
- KRRO
- Stock Information
- Founded
- CGC 2009
- KRRO 2014
- Country
- CGC Canada
- KRRO United States
- Employees
- CGC N/A
- KRRO N/A
- Industry
- CGC Pharmaceuticals and Biotechnology
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- CGC Health Care
- KRRO Health Care
- Exchange
- CGC Nasdaq
- KRRO Nasdaq
- Market Cap
- CGC 174.9M
- KRRO 209.6M
- IPO Year
- CGC N/A
- KRRO 2019
- Fundamental
- Price
- CGC $1.19
- KRRO $13.90
- Analyst Decision
- CGC Sell
- KRRO Strong Buy
- Analyst Count
- CGC 2
- KRRO 7
- Target Price
- CGC $2.00
- KRRO $106.33
- AVG Volume (30 Days)
- CGC 5.8M
- KRRO 110.5K
- Earning Date
- CGC 05-29-2025
- KRRO 05-13-2025
- Dividend Yield
- CGC N/A
- KRRO N/A
- EPS Growth
- CGC N/A
- KRRO N/A
- EPS
- CGC N/A
- KRRO N/A
- Revenue
- CGC $192,343,833.00
- KRRO $2,271,000.00
- Revenue This Year
- CGC N/A
- KRRO N/A
- Revenue Next Year
- CGC $2.50
- KRRO $20.00
- P/E Ratio
- CGC N/A
- KRRO N/A
- Revenue Growth
- CGC N/A
- KRRO N/A
- 52 Week Low
- CGC $0.77
- KRRO $11.13
- 52 Week High
- CGC $14.92
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- CGC 55.54
- KRRO 34.42
- Support Level
- CGC $0.77
- KRRO $12.21
- Resistance Level
- CGC $0.98
- KRRO $15.30
- Average True Range (ATR)
- CGC 0.13
- KRRO 2.09
- MACD
- CGC 0.05
- KRRO 0.21
- Stochastic Oscillator
- CGC 79.25
- KRRO 38.74
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.